BBLG — Bone Biologics Corp
—
Nasdaq ·
Health Care ·
Health Care Equipment & Supplies ·
CIK 1419554 ·
Last close
$0.50
Market Cap
$1.37M
52W High
$2.89
52W Low
$0.43
ADV30
235,160
Next earnings
—
Quarterly Fundamentals
Revenues vs Net Income (last 4 Q)
Assets vs Liabilities (last 4 Q)
| Period | Revenues | Gross profit | Op income | Net income | Assets | Cash | Liabilities |
|---|---|---|---|---|---|---|---|
| Jun 2026 | 0 | 0 | -808,106 | -773,702 | 4,436,668 | 4,031,780 | 512,018 |
| Mar 2026 | 0 | — | -805,054 | -765,988 | 4,979,305 | 4,530,040 | 309,386 |
| Dec 2025 | 0 | — | -733,105 | -684,643 | 5,796,135 | 5,334,322 | 418,587 |
| Sep 2025 | 0 | — | -715,274 | -666,737 | 6,350,799 | 6,049,084 | 334,282 |
Cashflow TTM (yfinance, fills SEC gap)
Operating CF
$-2,569,307
Investing CF
—
Financing CF
$4,352,792
CapEx
—
Dividends Paid
—
Buybacks
—
EPS Diluted TTM
$-4.05
As of
2026-08-16
Balance + Analyst (yfinance extras)
Retained Earnings
$-88,896,357
Inventory
—
Receivables
$7,809
ST Investments
—
EBIT TTM
$-3,001,508
Pretax Income TTM
$-2,857,887
Interest Exp TTM
—
Analysts
1
Annual Trend (SEC EDGAR, last 5y)
Revenues vs Net Income (last 5y)
| FY end | Revenues | Op income | Net income | Assets | Liabilities | Equity | Op cash flow |
|---|---|---|---|---|---|---|---|
| Dec 2025 | 0 | -3,234,942 | -3,108,991 | 5,796,135 | 418,587 | 5,377,548 | -2,691,150 |
| Dec 2024 | 0 | -4,219,161 | -4,112,420 | 3,861,369 | 377,712 | 3,483,657 | -4,124,935 |
| Dec 2023 | 0 | -9,428,303 | -8,948,731 | 3,737,763 | 831,402 | 2,906,361 | -9,555,904 |
| Dec 2022 | 0 | -3,665,173 | -1,484,620 | 8,495,237 | 2,547,929 | 5,947,308 | -3,566,913 |
| Dec 2021 | — | — | — | — | — | — | — |
TTM Snapshot
Revenues TTM
—
NetIncome TTM
—
OpCashFlow TTM
—
Assets (Latest)
—
Forward EPS
$-0.67
Peers — same industry
| Ticker | Name | Market Cap | Last | Daily % |
|---|---|---|---|---|
| BTCY | BIOTRICITY INC. | $1.39M | $0.07 | — |
| GCTK | Glucotrack, Inc. | $1.44M | $1.80 | — |
| ESMC | ESCALON MEDICAL CORP | $1.26M | $0.17 | — |
| NUMD | Nu-Med Plus, Inc. | $1.22M | $0.01 | — |
| ALUR | ALLURION TECHNOLOGIES, INC. | $1.13M | $1.13 | — |
News headlines (Yahoo Finance, 1h cache)
Bone Biologics Expands Trial Sites
2026-09-08 12:30 · Yahoo
BBLG Efficiency Improves as Crucial Trials Advance
2026-08-17 12:46 · Yahoo
Bone Biologics Extends rhNELL-1 Validated Shelf Life to 32 Months as NB1 Study Advances
2026-08-12 14:15 · Yahoo
Bone Biologics Achieves 32-Month Validated Shelf Life for rhNELL-1
2026-08-12 12:00 · Yahoo
BBLG Secures Financing for Critical Trials
2026-07-08 12:15 · Yahoo
Bone Biologics Announces up to $9.0 Million Private Placement Priced At-The-Market Under Nasdaq Rules
2026-07-08 00:00 · Yahoo
BBLG In Good Shape as Critical Tests Underway
2026-05-15 12:29 · Yahoo
Bone Biologics Improves Extension of rhNELL-1 Product Shelf Life to 24 Months
2025-12-23 13:00 · Yahoo
Bone Biologics Highlights 2025 Key Operational, Scientific, and Corporate Milestones and Provides 2026 Outlook
2026-01-08 13:00 · Yahoo
Bone Biologics Issues Mid-Year Shareholder Update Highlighting Progress Across 2026 Priorities
2026-07-23 12:00 · Yahoo
Recent Insider Activity
No insider activity indexed for this ticker.